News and Announcements
The Inner Workings of a VC Fund
- Published December 14, 2022 8:11AM UTC
- Publisher Osama Hassan
- Categories Capital Raising Tips
Let’s go over the inner workings of a VC fund:
A venture fund is a fixed-pool of capital raised for investing per an agreed-upon investment strategy.
A venture firm manages this fund, and over time, can manage multiple funds.
General Partners (GPs) are the primary investment decision makers and are generally supported by a team of admin and investment professionals.
Limited Partners (LPs) provide the capital and agree to pay the GP a management fee each year and a share in a percentage of the profits.
The goal for the LP is to make a superior risk-adjusted financial return and the primary measures of their success is: Internal Rate of Return (IRR) and cash-on-cash return (C-on-C), and the multiple of invested capital (MOIC).
Click here to view the original Linkedin post.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
